Diclofenac/Lidocaine

双氯芬酸/利多卡因

Report date: 2026/02/13 10:40:08

Base Information

Drug NameDiclofenac/Lidocaine
Drug Alias Name利多卡因/双氯芬酸lidocaine/DiclofenacDiclofenac+lidocaine双氯芬酸+利多卡因利多卡因+双氯芬酸 +[7] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsSodium channels blockers
TargetsCyclooxygenasesSodium channels
Therapy Area/IndicationsArrhythmias, CardiacHyperemesis GravidarumHerpes Labialis
Global Approved IndicationsArrhythmias, CardiacHyperemesis Gravidarum
Approved Indications in ChinaArrhythmias, CardiacHyperemesis Gravidarum
Original Approved Country/TerritoryMainland China
Original Approved Date2015/09/30
Country/TerritoryMainland China
CombinationsYes Diclofenac SodiumLidocaine
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesYung Shin Pharm Ind Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Sihuan Kebao Pharmaceutical Co Ltd
Inactive CompaniesYung Shin Pharm Ind Co Ltd
Active IndicationsArrhythmias, CardiacHyperemesis Gravidarum
Inactive IndicationsHerpes Labialis

Other Information

ATC CodeM01AB55N01BB52
Related LinksN/A